Effects of Intraperitoneal Cefazolin on Mesothelial Cells in Noninfected CAPD Patients

Abstract

Get full access to this article

View all access options for this article.

References

Ho-dac-Pannekeet

M.M.

, Hiralall

J.K.

, Struijk

D.G.

, Krediet

R.T.

Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.

Adv Perit Dial 1997; 13: 17–22.

Holmes

C.J.

Peritoneal host defense mechanisms in peritoneal dialysis.

Kidney Int 1994; 46(Suppl 48): S58–70.

Topley

, Williams

J.D.

Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.

Kidney Int 1994; 46(Suppl 48): S71–8.

Visser

C.E.

, Brouwer–Steenbergen

J.J.E.

, Betjes

M.G.H.

, Koomen

G.C.M.

, Beelen

R.H.J.

, Krediet

R.T.

Cancer antigen 125: A bulk marker for mesothelial mass in stable peritoneal dialysis patients.

Nephrol Dial Transplant 1995; 10: 64–9.

Pannekeet

M.M.

, Zemel

, Koomen

G.C.

, Struijk

D.G.

, Krediet

R.T.

Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.

Perit Dial Int 1995; 15: 217–25.

Pannekeet

M.M.

, Hiralall

J.K.

, Struijk

D.G.

, Krediet

R.T.

Longitudinal follow-up of CA125 in peritoneal effluent.

Kidney Int 1997; 51: 888–93.

Keane

W.F.

, Bailie

G.R.

, Boeschoten

, Gokal

, Golper

T.A.

, Holmes

C.J.

Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update (Published erratum appears in Perit Dial Int 2000; 20: 828–9).

Perit Dial Int 2000; 20: 396–411.

Manley

H.J.

, Bailie

G.R.

, Asher

R.D.

, Eisele

, Frye

R.F.

Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.

Perit Dial Int 1999; 19: 65–70.

Koomen

G.C.M.

, Betjes

M.G.H.

, Zemel

, Krediet

R.T.

, Hoek

F.J.

Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis.

Perit Dial Int 1994; 14: 132–6.

10.

AxSym system operations manual. Abbot Park, IL: Abbott Laboratories–Diagnostics Division, February, 1996.

11.

Smith

T.A.

II , Bailie

G.R.

, Eisele

Chemical peritonitis associated with intra-peritoneal vancomycin.

Drug Intell Clin Pharm 1991; 25: 602–3.

12.

Coronel

, Martin–Rabadan

, Romero

Chemical peritonitis after intraperitoneal administration of amphotericin B in a fungal infection of the catheter subcutaneous tunnel.

Perit Dial Int 1993; 13: 161–2.

13.

Fabris

, Contestabile

, Pellanda

M.V.

, Gardin

, De Vivo

, Guerini

Abdominal pain in a CAPD patient treated with intravenous adriamycin: A chemical peritonitis?

Perit Dial Int 2000; 20: 93–4.

14.

Monk

B.J.

, Surwit

E.A.

, Alberts

D.S.

, Graham

Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery.

Semin Oncol 1988; 15(3 Suppl 4): 27–31.

15.

Elwell

R.J.

, Bailie

G.R.

, Manley

H.J.

Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.

Perit Dial Int 2000; 20: 694–8.